Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of Dillenia suffruticosa

BMC Complementary and Alternative Medicine

Maznah Ismail¹  Norsharina Ismail¹  Mustapha Umar Imam¹  Rasedee Abdullah²  Yoke Kqueen Cheah³  Nurdin Armania¹  Jhi Biau Foo¹  Latifah Saiful Yazan³  Yin Sim Tor¹ 

[1] Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM, Serdang, Selangor, Malaysia;Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti, Putra Malaysia, 43400 UPM, Serdang, Selangor, Malaysia;Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra, Malaysia, 43400 UPM, Serdang, Selangor, Malaysia

关键词: Oxidative stress pathway;    Apoptosis;    Cytotoxic;    Breast cancer;    Dillenia suffruticosa;   

Others  :  1220266
DOI  :  10.1186/1472-6882-14-55

 received in 2013-07-15, accepted in 2014-02-10,  发布年份 2014

【 摘 要 】

Background

Breast cancer is one of the most dreading types of cancer among women. Herbal medicine has becoming a potential source of treatment for breast cancer. Herbal plant Dillenia suffruticosa (Griff) Martelli under the family Dilleniaceae has been traditionally used to treat cancerous growth. In this study, the anticancer effect of ethyl acetate extract of D. suffruticosa (EADs) was examined on human breast adenocarcinoma cell line MCF-7 and the molecular pathway involved was elucidated.

Methods

EADs was obtained from the root of D. suffruticosa by using sequential solvent extraction. Cytotoxicity was determined by using MTT assay, mode of cell death by cell cycle analysis and apoptosis induction by Annexin-FITC/PI assay. Morphology changes in cells were observed under inverted light microscope. Involvement of selected genes in the oxidative stress-mediated signaling pathway was explored using multiplex gene expression analysis.

Results

The treatment of EADs caused cytotoxicity to MCF-7 cells in a dose- and time-dependent manner at 24, 48 and 72 hours with IC₅₀ of 76 ± 2.3, 58 ± 0.7 and 39 ± 3.6 μg/mL, respectively. The IC₅₀ of tamoxifen-treated MCF-7 cells was 8 ± 0.5 μg/mL. Induction of apoptosis by EADs was dose- and time- dependent. EADs induced non-phase specific cell cycle arrest at different concentration and time point. The multiplex mRNA expression study indicated that EADs-induced apoptosis was accompanied by upregulation of the expression of SOD1, SOD2, NF-κB, p53, p38 MAPK, and catalase, but downregulation of Akt1.

Conclusion

It is suggested that EADs induced apoptosis in MCF-7 cells by modulating numerous genes which are involved in oxidative stress pathway. Therefore, EADs has the potential to act as an effective intervention against breast cancer cells.

【 授权许可】

   
2014 Tor et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]United States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report. http://www.cdc.gov/uscs webcite
• [2]ACS: Cancer Facts and Figures 2012. Cancers with Increasing Incidence Trends; 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf webcite
• [3]Siegel R, Naishadham D, Jemal A: Cancer statistics. CA Cancer J Clin 2012, 62(1):10--29. http://dx.doi.org/10.3322/caac.20138 webcite
• [4]Forman D, Ward E, Ferlay M, Jemal A, Bray F: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. http://dx.doi.org/10.3322/caac.20107 webcite
• [5]Kaufmann SH, Gores GJ: Apoptosis in cancer: cause and cure. BioEssays 2000, 22(11):1007-1017. http://dx.doi.org/10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4 webcite
• [6]McGill G, Fisher DE: Apoptosis in tumorigenesis and cancer therapy. Frontiers in Biosci: a J and virtual Lib 1997, 2:d353-d379. http://europepmc.org/abstract/MED/9230063 webcite
• [7]Sledge GW Jr, Miller KD: Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur J Cancer 2003, 39(12):1668-1675. http://dx.doi.org/10.1016/S0959-8049(03)00273-9 webcite
• [8]Kasibhatla S, Tseng B: Why target apoptosis in cancer treatment? Mol Cancer Ther 2003, 2(6):573-580. http://mct.aacrjournals.org/content/2/6/573.abstract webcite
• [9]Wong RSY: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011, 30:87. http://www.jeccr.com/content/30/1/87 webcite BioMed Central Full Text
• [10]Kroemer G, Dallaporta B, Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998, 60:619-642. http://dx.doi.org/10.1146/annurev.physiol.60.1.619 webcite
• [11]Lowe SW, Lin AW: Apoptosis in cancer. Carcinogenesis 2000, 21(3):485-495. http://dx.doi.org/10.1093/carcin/21.3.485 webcite
• [12]Simic MG, Bergtold DS, Karam LR: Generation of oxy radicals in biosystems. Mutation Res/Fundamental and Mol Mech of Mutagenesis 1989, 214(1):3-12. http://dx.doi.org/10.1016/0027-5107(89)90192-9 webcite
• [13]Kryston TB, Georgiev AB, Pissis P, Georgakilas AG: Role of oxidative stress and DNA damage in human carcinogenesis. Mutation Res/Fundamental and Mol Mech of Mutagenesis 2011, 711(1–2):193-201. http://dx.doi.org/10.1016/j.mrfmmm.2010.12.016 webcite
• [14]Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, Lleonart ME: Oxidative stress and cancer: an overview. Ageing Res Rev 2013, 12(1):376-390. http://dx.doi.org/10.1016/j.arr.2012.10.004 webcite
• [15]Dreher D, Junod AF: Role of oxygen free radicals in cancer development. Eur J Cancer 1996, 32(1):30-38. http://dx.doi.org/10.1016/0959-8049(95)00531-5 webcite
• [16]Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160(1):1-40. http://dx.doi.org/10.1016/j.cbi.2005.12.009 webcite
• [17]Wen J, You K-R, Lee S-Y, Song C-H, Kim D-G: Oxidative stress-mediated apoptosis: the anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 2002, 277(41):38954-38964. http://dx.doi.org/10.1074/jbc.M203842200 webcite
• [18]Afzal S, Jensen S, Sørensen J, Henriksen T, Weimann A, Poulsen H: Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin. Cancer Chemother Pharmacol 2012, 69(2):301-307. http://dx.doi.org/10.1007/s00280-011-1700-2 webcite
• [19]Alexandre J, Hu Y, Lu W, Pelicano H, Huang P: Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 2007, 67(8):3512-3517. http://dx.doi.org/10.1158/0008-5472.can-06-3914 webcite
• [20]Nazarewicz RR, Zenebe WJ, Parihar A, Larson SK, Alidema E, Choi J, Ghafourifar P: Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res 2007, 67(3):1282-1290. http://dx.doi.org/10.1158/0008-5472.can-06-3099 webcite
• [21]Graham JG, Quinn ML, Fabricant DS, Farnsworth NR: Plants used against cancer – an extension of the work of Jonathan Hartwell. J Ethnopharmacol 2000, 73:347-377. http://www.sciencedirect.com/science/article/pii/S037887410000341X webcite
• [22]Farnsworth NR: The Role of Etnopharmacology in Drug Development. England: John Wiley Chichester; 1990. http://www.ncbi.nlm.nih.gov/pubmed/2086037 webcite
• [23]Liu JH: Activation of apoptosis pathways by different classes of anticancer drugs. Hubei: University of Ulm; 2001. http://vts.uni-ulm.de/docs/2001/798/vts_798.pdf webcite
• [24]Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 1997, 89(6):1845-1853. http://bloodjournal.hematologylibrary.org/content/89/6/1845.short webcite
• [25]Debatin K-M: Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 2000, 112–113(0):41-48. http://dx.doi.org/10.1016/S0378-4274(99)00252-0 webcite
• [26]Hickman J: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992, 11(2):121-139. http://dx.doi.org/10.1007/BF00048059 webcite
• [27]Yeh CC, Tseng CN, Yang JI, Huang HW, Fang Y, Tang JY, Chang FR, Chang HW: Antiproliferation and induction of apoptosis in Ca9-22 oral cancer cells by ethanolic extract of gracilaria tenuistipitata. Molecules 2012, 17(9):10916-10927. http://www.mdpi.com/1420-3049/17/9/10916 webcite
• [28]Yoo C-B, Han K-T, Cho K-S, Ha J, Park H-J, Nam J-H, Kil U-H, Lee K-T: Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett 2005, 225(1):41-52. http://dx.doi.org/10.1016/j.canlet.2004.11.018 webcite
• [29]Altinok B, Sunguroglu A, Karadag A, Gurleyik E, Ozkan T, Aydos OS, Avci A: Antiproliferative, apoptotic and antioxidant activities of wheatgrass (Triticum aestivum L.) extract on CML (K562) cell line. Turkish J of Med Sci 2011, 41(4):657-663. http://journals.tubitak.gov.tr/medical/issues/sag-11-41-4/sag-41-4-13-0912-425.pdf webcite
• [30]Xiao D, Zeng Y, Prakash L, Badmaev V, Majeed M, Singh SV: Reactive oxygen species-dependent apoptosis by gugulipid extract of ayurvedic medicine plant commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase. The Am Soc for Pharmacol and Exp Ther 2010, 79:499-507. http://dx.doi.org/10.1124/mol.110.068551 webcite
• [31]Chong KY, Tan HTW, Corlett RT: A checklist of the total vascular plant flora of Singapore: native, naturalised and cultivated species. Raffles Museum of Biodiversity Research, National University of Singapore. Singapore: Raffles Museum of Biodiversity Research, National University of Singapore; 2009:273. http://rmbr.nus.edu.sg/raffles_museum_pub/flora_of_singapore_tc.pdf webcite
• [32]U.S. Department Agriculture ARS: National Genetic Resources Program. USA: Germplasm Resources Information Network (GRIN). Online searchable database; 2011. http://www.ars-grin.gov/cgi-bin/npgs/html/index.pl webcite
• [33]Ahmad FB, Holdsworth DK: Traditional medicinal plants of Sabah, Malaysia part III. The Rungus people of Kudat. Int J Pharmacogn 1995, 33:262-264. http://dx.doi.org/10.3109/13880209509065377 webcite
• [34]Hanum F, Hamzah N: The use of medicinal plant species by the Temuan tribe of Ayer Hitam Forest, Selangor, Peninsular Malaysia. Pertanika J of Tropical Agri 1999, 22(2):85-94. http://psasir.upm.edu.my/3802/1/The_Use_of_Medicinal_Plant_Species_by_the_Temuan_Tribe_of_Ayer_Hitam.pdf webcite
• [35]Wiart C, Mogana S, Khalifah S, Mahan M, Ismail S, Buckle M, Narayana AK, Sulaiman M: Antimicrobial screening of plants used for traditional medicine in the state of Perak, Peninsular Malaysia. Fitoterapia 2004, 75(1):68-73. http://www.sciencedirect.com/science/article/pii/S0367326X03002089 webcite
• [36]Muliawan SY: Effect of Dillenia suffruticosa extract on dengue virus type 2 replication. Universa Med 2008, 27(1):1-5. http://www.univmed.org/wp-content/uploads/2011/02/dr.sylvia.pdf webcite
• [37]Armania N, Yazan L, Musa SN, Ismail IS, Foo JB, Chan KW, Noreen H, Hisyam AH, Zulfahmi S, Ismail M: Dillenia suffruticosa exhibited antioxidant and cytotoxic activity through induction of apoptosis and G2/M cell cycle arrest. J Ethnopharmacol 2013, 146(2):525-535. http://dx.doi.org/10.1016/j.jep.2013.01.017 webcite
• [38]Wang CZ, Li XL, Wang QF, Mehendale SR, Yuan CS: Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells. Phytomedicine 2010, 17(1):63-68. http://dx.doi.org/10.1016/j.phymed.2009.07.003 webcite
• [39]Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1–2):55-63. http://dx.doi.org/10.1016/0022-1759(83)90303-4 webcite
• [40]Hanahan D, Weinberg Robert A: Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013 webcite
• [41]Fulda S: Modulation of apoptosis by natural products for cancer therapy. Planta Med 2010, 76(EFirst):1075-1079. http://dx.doi.org/10.1055/s-0030-1249961 webcite
• [42]Bailly C: Ready for a comeback of natural products in oncology. Biochem Pharmacol 2009, 77(9):1447-1457. http://dx.doi.org/10.1016/j.bcp.2008.12.013 webcite
• [43]Taraphdar AK, Roy M, Bhattacharya RK: Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr Sci 2001, 80(11):1387-1396. http://www.iisc.ernet.in/currsci/jun102001/1387.pdf webcite
• [44]Man S, Gao W, Zhang Y, Huang L, Liu C: Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia 2010, 81(7):703-714. http://dx.doi.org/10.1016/j.fitote.2010.06.004 webcite
• [45]Zhiyu W, Yue C, Neng W, Mei WD, Wei LY, Feng H, Gang SJ, De Po Y, Yuan GX, Jian-Ping C: Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol & Therapy 2012, 13(3):138-147. http://www.landesbioscience.com/journals/cbt/article/18693/ webcite
• [46]Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, Luong JHT, Lai GM, Tzeng YM: Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett 2009, 285(1):73-79. http://dx.doi.org/10.1016/j.canlet.2009.05.002 webcite
• [47]Lamoral-Theys D, Pottier L, Dufrasne F, Neve J, Dubois J, Kornienko A, Kiss R, Ingrassia L, Lamoral-Theys D, Pottier L, Dufrasne F, Neve J, Dubois J, Kornienko A, Kiss R, Ingrassia L: Natural polyphenols that display anticancer properties through inhibition of kinase activity. Curr Med Chem 2010, 17(814):812-825. http://dx.doi.org/10.2174/092986710790712183 webcite
• [48]Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R: Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol 2007, 595:173-184. http://link.springer.com/chapter/10.1007%2F978-0-387-46401-5_6 webcite
• [49]Barton-Burke M, Wilkes GM: Cancer Therapies. 10th edition. United States of America: Jones and Barlett’s books; 2006.
• [50]Ozawa S, Sugiyama Y, Mitsuhashi Y, Kobayashi T, Inaba M: Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product. Cancer Chemother Pharmacol 1988, 21(3):185-190. http://dx.doi.org/10.1007/bf00262767 webcite
• [51]Fadok VA, Voelker DR, Campbell PA, Cohen JJ DLB, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207. http://www.jimmunol.org/content/148/7/2207.long webcite
• [52]Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C: A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995, 184(1):39-51. http://dx.doi.org/10.1016/0022-1759(95)00072-I webcite
• [53]Zhang G, Gurtu V, Kain SR, Yan G: Early detection of apoptosis using a fluorescent conjugate of annexin V. BioTechniques 1997, 23:525-531. http://www.biotechniques.com/multimedia/archive/00011/97233pf01_11715a.pdf webcite
• [54]Schutte B, Nuydens R, Geerts H, Ramaekers F: Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells. J Neurosci Methods 1998, 86(1):63-69. http://dx.doi.org/10.1016/S0165-0270(98)00147-2 webcite
• [55]Jänicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998, 273(16):9357-9360. http://dx.doi.org/10.1074/jbc.273.16.9357 webcite
• [56]Jänicke R: MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009, 117(1):219-221. http://dx.doi.org/10.1007/s10549-008-0217-9 webcite
• [57]Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PR: Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells. Br J Cancer 2002, 87(8):909-917. http://europepmc.org/abstract/MED/12373608 webcite
• [58]Kasibhatla S, Genestier L, Green DR: Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB. J Biol Chem 1999, 274(2):987-992. http://dx.doi.org/10.1074/jbc.274.2.987 webcite
• [59]Kong Q, Beel JA, Lillehei KO: A threshold concept for cancer therapy. Med Hypotheses 2000, 55(1):29-35. http://dx.doi.org/10.1054/mehy.1999.0982 webcite
• [60]Kinnula VL, Crapo JD: Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004, 36(6):718-744. http://dx.doi.org/10.1016/j.freeradbiomed.2003.12.010 webcite
• [61]Salganik RI: The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001, 20(5):464S-472S. http://www.ncbi.nlm.nih.gov/pubmed/11603657 webcite
• [62]Miller WH, Ratna S, Rincón SVD, Rousseau : Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. Oncogene 2002, 22(3353):3360. http://dx.doi.org/10.1038/sj.onc.1206485 webcite
• [63]Diao Y, Huang YQ, Zhang GD, Huang KF: Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K–AKT pathway. Int Immunopharmacol 2012, 12(2):334-341. http://dx.doi.org/10.1016/j.intimp.2011.12.004 webcite
• [64]Testa JR, Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci 2001, 98(20):10983-10985. http://dx.doi.org/10.1073/pnas.211430998 webcite
• [65]Martindale JL, Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and survival. J of Cell Physiol 2002, 192(1):15. http://dx.doi.org/10.1002/jcp.10119 webcite
• [66]Chang YJ, Huang YP, Li ZL, Chen CH: GRP78 Knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells. PLoS ONE 2012, 7(4):e35123. http://dx.doi.org/10.1371/journal.pone.0035123s webcite
• [67]Toker A, Yoeli-Lerner M: Akt signaling and cancer: surviving but not moving on. Cancer Res 2006, 66(8):3963-3966. http://dx.doi.org/10.1158/0008-5472.can-06-0743 webcite
• [68]Bates S, Vousden KH: Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci 1999, 55:28-37. http://www.ncbi.nlm.nih.gov/pubmed/10065149sss webcite
• [69]Robbins D, Zhao Y: Oxidative stress induced byMnSOD-p53 interaction: Pro- or anti-tumorigenic? J of Signal Transduct 2012, 2012:1-13. http://dx.doi.org/10.1155/2012/101465 webcite
• [70]Sethi G, Sung B, Aggarwal BB: Nuclear factor-κB activation: from bench to bedside. Exp Biol and Med 2008, 233(1):21-31. http://dx.doi.org/10.3181/0707-mr-196 webcite
• [71]Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y: Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001, 38(1):48-55. http://dx.doi.org/10.1161/01.hyp.38.1.48 webcite
• [72]Martin AG: NFkB anti-apoptotic or pro-apoptotic, maybe both. Cell Cycle 2010, 9(16):3131-3132. http://www.mendeley.com/download/public/14520753/4840739732/054ce21125d09cd5018cfb8b4e375f6646499037/dl.pdf webcite
• [73]Janssen-Heininger YMW, Poynter ME, Baeuerle PA: Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb. Free Radic Biol Med 2000, 28(9):1317-1327. http://dx.doi.org/10.1016/S0891-5849(00)00218-5 webcite
• [74]Zarubin T, Han J: Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005, 15:11-18. http://dx.doi.org/doi:10.1038/sj.cr.7290257 webcite
• [75]Park K-R, Nam D, Yun H-M, Lee S-G, Jang H-J, Sethi G, Cho SK, Ahn KS: β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 2011, 312(2):178-188. http://dx.doi.org/10.1016/j.canlet.2011.08.001 webcite
• [76]Massaoka MH, Matsuo AL, Figueiredo CR, Farias CF, Girola N, et al.: Jacaranone induces apoptosis in melanoma cells via ROS-mediated downregulation of Akt and p38 MAPK activation and displays antitumor activity in vivo. PLoS ONE 2012, 7(6):e38698. http://dx.doi.org/10.1371/journal.pone.0038698 webcite
• [77]Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC: Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 2001, 276(32):30359-30365. http://dx.doi.org/10.1074/jbc.M009698200 webcite
• [78]Romashkova JA, Makarov SS: NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401(86):90. http://dx.doi.org/10.1038/43474 webcite
• [79]Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996, 274(5288):787-789. http://dx.doi.org/10.1126/science.274.5288.787 webcite